CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.270
-0.050 (-1.51%)
At close: Jun 25, 2026, 4:00 PM EDT
3.260
-0.010 (-0.31%)
After-hours: Jun 25, 2026, 5:12 PM EDT
CytomX Therapeutics Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, CytomX Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $12.5. The average 1-year stock price forecast is 282.26% higher than the current stock price, while the lowest is $6.00 (+83.49%) and the highest is $16 (+389.30%).
Price Target: $12.5 (+282.26%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CytomX Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 6 | 5 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +236.39% | Jun 4, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $6 | Buy | Initiates | $6 | +83.49% | May 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $17 → $11 | Buy | Maintains | $17 → $11 | +236.39% | May 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +266.97% | May 8, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $15 | Buy | Maintains | $15 | +358.72% | May 8, 2026 |
Financial Forecast
Revenue This Year
35.75M
from 76.20M
Decreased by -53.09%
Revenue Next Year
34.26M
from 35.75M
Decreased by -4.17%
EPS This Year
-0.42
from -0.15
EPS Next Year
-0.49
from -0.42
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 80.0M | ||
| Avg | 35.7M | ||
| Low | 10.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.0% | ||
| Avg | -53.1% | ||
| Low | -86.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.34 | ||
| Avg | -0.42 | ||
| Low | -0.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |